Patients undergoing conventional chemotherapy for certain cancers could potentially receive more effective and less toxic drug treatment. In a July issue of the journal Proceedings of the National Academy of Sciences (PNAS), ...
Aug 8, 2017
0
183
Ovarian cancer is a difficult to diagnose malignancy that is often caught at a more advanced stage. Treatments for this cancer have changed little over the past few decades, with surgery and chemotherapy being the most common ...
Apr 14, 2022
0
62
Medicines used to prevent bone loss may help lower the risk of ovarian cancer according to research by The University of Queensland.
Jun 17, 2022
0
5
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.
Jan 12, 2018
0
134
Ovarian cancer is the most deadly gynecological cancer, claiming the lives of more than 50% of women who are diagnosed with the disease. A study involving Ottawa and Taiwan researchers, published today in the influential ...
Sep 24, 2014
0
0
Immunotherapy treatments have proven wildly successful in treating some patients with cancer. But despite this success, the majority of patients do not respond to the treatments.
Oct 26, 2015
1
67
A new study has found that nearly one third of older adult female survivors of colorectal, endometrial and ovarian cancer have quality of life-impacting challenges with physical activity due to chronic swelling (lymphedema) ...
Mar 9, 2022
0
59
Did you know that 90% of cancer patients die from distant metastasis? The latter occurs when cancer cells have the ability to move within the patient's body and invade its healthy tissues. In a study published in Nature Communications, ...
Jul 10, 2019
0
232
Inherited mutations in the BRCA1 gene can significantly increase a person's risk of breast and ovarian cancer—but not every mutation in the gene is harmful. To better equip patients and their doctors to understand and manage ...
Jun 3, 2022
0
33
Cambridge scientists have created a comprehensive tool for predicting an individual's risk of developing prostate cancer, which they say could help ensure that those men at greatest risk will receive the appropriate testing ...
Dec 9, 2022
0
390
